Selective intraarterial radionuclide radiotherapy of inoperable liver metastases with Yttrium-90 (Y-90) labeled microspheres in a patient with medullary thyroid carcinoma metastasis in the liver: first national administration

Selective intraarterial radionuclide radiotherapy of inoperable liver metastases with Yttrium-90 (Y-90) labeled microspheres in a patient with medullary thyroid carcinoma metastasis in the liver: first national administration

Radioembolization of inoperable primary or metastatic liver cancers with Yttrium-90 (Y-90) labeled radiomicrospheres is a treatment modality with its efficacy established. It is possible to administer curative doses of radiation to the tumor tissue while preserving normal liver parenchyma to a large...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Gülhane Tip Dergisi 2012-03, Vol.54 (1), p.57
Hauptverfasser: Arslan, Nuri, Bahri Üstünsöz, Alagöz, Engin, Şahin Uğurel, Öztürk, Erkan, Turgut Tufan, Mehmet Ali Özgüven
Format: Artikel
Sprache:eng ; tur
Schlagworte:
Liver
Metastasis
Thyroid cancer
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 1
container_start_page 57
container_title Gülhane Tip Dergisi
container_volume 54
creator Arslan, Nuri
Bahri Üstünsöz
Alagöz, Engin
Şahin Uğurel
Öztürk, Erkan
Turgut Tufan
Mehmet Ali Özgüven
description Radioembolization of inoperable primary or metastatic liver cancers with Yttrium-90 (Y-90) labeled radiomicrospheres is a treatment modality with its efficacy established. It is possible to administer curative doses of radiation to the tumor tissue while preserving normal liver parenchyma to a large extent with selective intraarterial radionuclide therapy performed with Y-90 labeled microspheres. Selective intraarterial radionuclide therapy with SIRSpheres ® was approved by Turkish Ministry of Health for the treatment of inoperable liver cancers in April 2008. In this study, the results of selective intraarterial radionuclide therapy performed with SIR-Spheres® for the first time in Turkey in a 32-year-old male patient with inoperable liver metastasis due to medullary thyroid carcinoma are presented.
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_2440155705</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2440155705</sourcerecordid><originalsourceid>FETCH-proquest_journals_24401557053</originalsourceid><addsrcrecordid>eNqNT81KxEAMLqLg-vMOAS96KEy7bXf1Kop3vexpybZZNst0pmZSpY_rmxhd8bwQEr7w_SQn2awsqiZfuro8zWbF3JW5qxbFeXaR0t65pqmL5Sz7eiVPrfIHAQcVRFESRg-CHccwtp47OgDdkeAwQdwaNQ4GNp7Am1SgJ8VkRQk-WXewUhUe-_zewe3K-h143FhSBz23EtNgXsblAAgDKlPQg7CnbvQeZQLdTRK5gxaltbwe_0P4V2jnHMIfYMuSFIL5xGCnY9dz4GTf_CyusrMt-kTXf_Myu3l-ent8yQeJ7yMlXe_jKKZL67KqXFHXC1fPj2N9Azrrd3I</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2440155705</pqid></control><display><type>article</type><title>Selective intraarterial radionuclide radiotherapy of inoperable liver metastases with Yttrium-90 (Y-90) labeled microspheres in a patient with medullary thyroid carcinoma metastasis in the liver: first national administration</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Arslan, Nuri ; Bahri Üstünsöz ; Alagöz, Engin ; Şahin Uğurel ; Öztürk, Erkan ; Turgut Tufan ; Mehmet Ali Özgüven</creator><creatorcontrib>Arslan, Nuri ; Bahri Üstünsöz ; Alagöz, Engin ; Şahin Uğurel ; Öztürk, Erkan ; Turgut Tufan ; Mehmet Ali Özgüven</creatorcontrib><description>Radioembolization of inoperable primary or metastatic liver cancers with Yttrium-90 (Y-90) labeled radiomicrospheres is a treatment modality with its efficacy established. It is possible to administer curative doses of radiation to the tumor tissue while preserving normal liver parenchyma to a large extent with selective intraarterial radionuclide therapy performed with Y-90 labeled microspheres. Selective intraarterial radionuclide therapy with SIRSpheres ® was approved by Turkish Ministry of Health for the treatment of inoperable liver cancers in April 2008. In this study, the results of selective intraarterial radionuclide therapy performed with SIR-Spheres® for the first time in Turkey in a 32-year-old male patient with inoperable liver metastasis due to medullary thyroid carcinoma are presented.</description><identifier>ISSN: 1302-0471</identifier><identifier>EISSN: 2146-8052</identifier><language>eng ; tur</language><publisher>Ankara: Gulhane Medical Journal</publisher><subject>Liver ; Metastasis ; Thyroid cancer</subject><ispartof>Gülhane Tip Dergisi, 2012-03, Vol.54 (1), p.57</ispartof><rights>2012. This work is published under https://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,782,786</link.rule.ids></links><search><creatorcontrib>Arslan, Nuri</creatorcontrib><creatorcontrib>Bahri Üstünsöz</creatorcontrib><creatorcontrib>Alagöz, Engin</creatorcontrib><creatorcontrib>Şahin Uğurel</creatorcontrib><creatorcontrib>Öztürk, Erkan</creatorcontrib><creatorcontrib>Turgut Tufan</creatorcontrib><creatorcontrib>Mehmet Ali Özgüven</creatorcontrib><title>Selective intraarterial radionuclide radiotherapy of inoperable liver metastases with Yttrium-90 (Y-90) labeled microspheres in a patient with medullary thyroid carcinoma metastasis in the liver: first national administration</title><title>Gülhane Tip Dergisi</title><description>Radioembolization of inoperable primary or metastatic liver cancers with Yttrium-90 (Y-90) labeled radiomicrospheres is a treatment modality with its efficacy established. It is possible to administer curative doses of radiation to the tumor tissue while preserving normal liver parenchyma to a large extent with selective intraarterial radionuclide therapy performed with Y-90 labeled microspheres. Selective intraarterial radionuclide therapy with SIRSpheres ® was approved by Turkish Ministry of Health for the treatment of inoperable liver cancers in April 2008. In this study, the results of selective intraarterial radionuclide therapy performed with SIR-Spheres® for the first time in Turkey in a 32-year-old male patient with inoperable liver metastasis due to medullary thyroid carcinoma are presented.</description><subject>Liver</subject><subject>Metastasis</subject><subject>Thyroid cancer</subject><issn>1302-0471</issn><issn>2146-8052</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNqNT81KxEAMLqLg-vMOAS96KEy7bXf1Kop3vexpybZZNst0pmZSpY_rmxhd8bwQEr7w_SQn2awsqiZfuro8zWbF3JW5qxbFeXaR0t65pqmL5Sz7eiVPrfIHAQcVRFESRg-CHccwtp47OgDdkeAwQdwaNQ4GNp7Am1SgJ8VkRQk-WXewUhUe-_zewe3K-h143FhSBz23EtNgXsblAAgDKlPQg7CnbvQeZQLdTRK5gxaltbwe_0P4V2jnHMIfYMuSFIL5xGCnY9dz4GTf_CyusrMt-kTXf_Myu3l-ent8yQeJ7yMlXe_jKKZL67KqXFHXC1fPj2N9Azrrd3I</recordid><startdate>20120301</startdate><enddate>20120301</enddate><creator>Arslan, Nuri</creator><creator>Bahri Üstünsöz</creator><creator>Alagöz, Engin</creator><creator>Şahin Uğurel</creator><creator>Öztürk, Erkan</creator><creator>Turgut Tufan</creator><creator>Mehmet Ali Özgüven</creator><general>Gulhane Medical Journal</general><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20120301</creationdate><title>Selective intraarterial radionuclide radiotherapy of inoperable liver metastases with Yttrium-90 (Y-90) labeled microspheres in a patient with medullary thyroid carcinoma metastasis in the liver: first national administration</title><author>Arslan, Nuri ; Bahri Üstünsöz ; Alagöz, Engin ; Şahin Uğurel ; Öztürk, Erkan ; Turgut Tufan ; Mehmet Ali Özgüven</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_24401557053</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng ; tur</language><creationdate>2012</creationdate><topic>Liver</topic><topic>Metastasis</topic><topic>Thyroid cancer</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Arslan, Nuri</creatorcontrib><creatorcontrib>Bahri Üstünsöz</creatorcontrib><creatorcontrib>Alagöz, Engin</creatorcontrib><creatorcontrib>Şahin Uğurel</creatorcontrib><creatorcontrib>Öztürk, Erkan</creatorcontrib><creatorcontrib>Turgut Tufan</creatorcontrib><creatorcontrib>Mehmet Ali Özgüven</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Gülhane Tip Dergisi</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Arslan, Nuri</au><au>Bahri Üstünsöz</au><au>Alagöz, Engin</au><au>Şahin Uğurel</au><au>Öztürk, Erkan</au><au>Turgut Tufan</au><au>Mehmet Ali Özgüven</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Selective intraarterial radionuclide radiotherapy of inoperable liver metastases with Yttrium-90 (Y-90) labeled microspheres in a patient with medullary thyroid carcinoma metastasis in the liver: first national administration</atitle><jtitle>Gülhane Tip Dergisi</jtitle><date>2012-03-01</date><risdate>2012</risdate><volume>54</volume><issue>1</issue><spage>57</spage><pages>57-</pages><issn>1302-0471</issn><eissn>2146-8052</eissn><abstract>Radioembolization of inoperable primary or metastatic liver cancers with Yttrium-90 (Y-90) labeled radiomicrospheres is a treatment modality with its efficacy established. It is possible to administer curative doses of radiation to the tumor tissue while preserving normal liver parenchyma to a large extent with selective intraarterial radionuclide therapy performed with Y-90 labeled microspheres. Selective intraarterial radionuclide therapy with SIRSpheres ® was approved by Turkish Ministry of Health for the treatment of inoperable liver cancers in April 2008. In this study, the results of selective intraarterial radionuclide therapy performed with SIR-Spheres® for the first time in Turkey in a 32-year-old male patient with inoperable liver metastasis due to medullary thyroid carcinoma are presented.</abstract><cop>Ankara</cop><pub>Gulhane Medical Journal</pub><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1302-0471
ispartof Gülhane Tip Dergisi, 2012-03, Vol.54 (1), p.57
issn 1302-0471
2146-8052
language eng ; tur
recordid cdi_proquest_journals_2440155705
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Liver
Metastasis
Thyroid cancer
title Selective intraarterial radionuclide radiotherapy of inoperable liver metastases with Yttrium-90 (Y-90) labeled microspheres in a patient with medullary thyroid carcinoma metastasis in the liver: first national administration
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-05T04%3A08%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Selective%20intraarterial%20radionuclide%20radiotherapy%20of%20inoperable%20liver%20metastases%20with%20Yttrium-90%20(Y-90)%20labeled%20microspheres%20in%20a%20patient%20with%20medullary%20thyroid%20carcinoma%20metastasis%20in%20the%20liver:%20first%20national%20administration&rft.jtitle=Gu%CC%88lhane%20Tip%20Dergisi&rft.au=Arslan,%20Nuri&rft.date=2012-03-01&rft.volume=54&rft.issue=1&rft.spage=57&rft.pages=57-&rft.issn=1302-0471&rft.eissn=2146-8052&rft_id=info:doi/&rft_dat=%3Cproquest%3E2440155705%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2440155705&rft_id=info:pmid/&rfr_iscdi=true